University Of Maryland, Baltimore

This study tests whether a special eye scan (OCT) can detect changes in immune cells in the retina of people with multiple sclerosis (MS) who start a new medication called ublituximab (Briumvi). Researchers will compare 15 people starting ublituximab with 15 people on stable MS t…

This study will test two new risk scores that predict a patient's chance of developing sepsis or having a serious decline (like cardiac arrest) within the next four hours. The goal is to help hospital staff notice high-risk patients sooner by checking vital signs more quickly. Ab…